Staged treatment of central and peripheral lesions in chronic thromboembolic pulmonary hypertension by Kopeć, Grzegorz et al.
97CLINICAL IMAGE Staged treatment of central and peripheral lesions in chronic...
without major complications. During follow-up, 
the patient still complained of exertional dys-
pnea (WHO-FC III). Lung scintigraphy revealed 
multiple mismatched segmental perfusion de-
fects in both lungs. RHC performed 9 months 
after PEA revealed persistent PH with an mPAP 
of 38 mmHg, PVR of 9.7 WU, CI of 1.6 l/min/m2, 
and RAP of 17 mmHg. Pulmonary angiography 
(FIGURES 1C and 1D) showed incomplete revascular-
ization of pulmonary vasculature. Since riociguat, 
the only approved drug for persistent CTEPH, was 
not available at that time, the patient was direct-
ly referred for BPA. Between January and June 
2015, she underwent 5 sessions of BPA with a to-
tal number of 32 lesions treated, including recan-
alization of 3 total occlusions. Three sessions were 
devoted to treat 14 lesions including 1 total occlu-
sion in RPA branches and 2 sessions to dilate 15 
lesions and to recanalize 2 occlusions in left pul-
monary artery branches. Catheter balloons with 
diameters ranging between 2.0 and 7.0 mm were 
used. An example of a BPA procedure in the up-
per lobe anterior (A3) branch of the left pulmo-
nary artery is shown in FIGURE 1E and 1F. No com-
plications occurred during or after any of the BPA 
sessions. BPA led to a decrease of mPAP to 24 
mmHg, PVR to 4.1 WU, mean RAP to 4 mmHg, 
and an increase of CI to 2.8 l/min/m2. It also re-
sulted in a significant clinical improvement with 
an increase of 6-minute walking distance from 
200 m to 340 m and a decrease of the WHO-FC 
from III to II. These effects were still present 3 
months after the last BPA session.
We conclude that a combination of PEA with 
subsequent BPA can be a therapeutic option for 
patients with CTEPH and a coexistence of cen-
tral and peripheral lesions.
Pulmonary endarterectomy (PEA) is a meth-
od of choice for the treatment of chronic throm-
boembolic pulmonary hypertension (CTEPH).1,2 
However, in a substantial number of patients, 
organized thrombi are located peripherally and 
are not easily accessible during PEA. These pa-
tients are at risk for persistent pulmonary hy-
pertension (PH) after PEA. We present a case of 
a patient with central and peripheral organized 
thrombi, in whom a combination of PEA and sub-
sequent percutaneous balloon pulmonary angio-
plasty (BPA)3-5 eventually led to near-normaliza-
tion of pulmonary hemodynamics. Despite pos-
sible serious complications of PEA (reperfusion 
lung injury, neurological complications, persistent 
PH, or death) and BPA (reperfusion lung injury, 
vessel rupture, or death), the benefits clearly out-
weigh the risk of these procedures.1-3
A 65-year-old woman with a history of acute 
pulmonary embolism was referred to a PH cen-
ter due to chronic dyspnea (World Health Orga-
nization functional class [WHO-FC] IV) and typ-
ical echocardiographic sings of precapillary PH. 
Computed tomography pulmonary angiography 
showed organized thrombi in the segmental and 
subsegmental arteries of both lungs. Right heart 
catheterization (RHC) and conventional left and 
right pulmonary angiography confirmed the di-
agnosis of CTEPH. Mean pulmonary artery pres-
sure (mPAP) was 52 mmHg; pulmonary vascular 
resistance (PVR), 10.3 Wood units (WU); right 
atrial pressure (RAP), 10 mmHg; and cardiac in-
dex (CI), 2.1 l/min/m2. Pulmonary angiography 
(FIGURES 1A and 1B) revealed numerous organized 
thrombi in the segmental and subsegmental ar-
teries of both lungs, including total occlusions, 
webs and bends, and abrupt narrowings. The pa-
tient was referred for PEA, which was performed 
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FIGURE 1 Pulmonary angiography of the right (A, B) and left (C, D) pulmonary arteries before (A, C) and after (B, D) pulmonary 
endarterectomy shows incomplete revascularization of pulmonary vasculature. Balloon pulmonary angioplasty of a totally 
occluded upper lobe anterior (A3) branch of the left pulmonary artery with catheter balloons, 1.25 mm and 2.0 mm (frame in 
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